Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301665
Status:
COMPLETED
Last Update Posted:
2020-04-24
First Post:
2006-03-09
Brief Title:
Efficacy and Safety Study of Dysport Used for Migraine Prophylaxis
Sponsor:
Ipsen
Organization:
Ipsen
Study Overview
Official Title:
A Phase II Multicentre Randomised Double-blind Parallel Groups Placebo Controlled Clinical Study of Efficacy and Safety of Dysport for Migraine Prophylaxis
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of botulinum toxin type A Dysport injections into pericranial muscles compared to placebo to prevent migraine attacks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None